Lv41
450 积分 2025-04-22 加入
Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment
1小时前
待确认
NADPH Oxidases‐Inspired Reactive Oxygen Biocatalysts with Electron‐Rich Pt Sites to Potently Amplify Immune Checkpoint Blockade Therapy
1个月前
已完结
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
1个月前
已完结
Dendritic cells and the control of immunity
1个月前
已完结
anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cells
2个月前
已完结
Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development
2个月前
已完结
Anlotinib combined with osimertinib reverses acquired osimertinib resistance in NSCLC by targeting the c-MET/MYC/AXL axis
2个月前
已完结
Combination of anlotinib with immunotherapy enhanced both anti-angiogenesis and immune response in high-grade serous ovarian cancer
2个月前
已完结
Anlotinib Induces a T Cell–Inflamed Tumor Microenvironment by Facilitating Vessel Normalization and Enhances the Efficacy of PD-1 Checkpoint Blockade in Neuroblastoma
2个月前
已完结
Anlotinib may enhance the efficacy of anti-PD1 therapy by inhibiting the AKT pathway and promoting the apoptosis of CAFs in lung adenocarcinoma
2个月前
已完结
皖公网安备34019202002308
